Study Summary
This trial is testing whether an electronic symptom management system can help people with stage 3 and 4 cancer live longer, specifically those who live in rural areas.
Eligible Conditions
- Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 4 Secondary · Reporting Duration: through study completion, an average of two years
Month 24
Change in Symptoms measured using the Patient-Reported Outcomes Measurement Information System: The PROMIS ®-Preference (PROPr)
Month 24
Change in Health-Related Quality of Life measured using the 36-Item Short Form Health Survey (SF-36)
Change in Physical Function measured using the Short Physical Performance Battery (SPPB)
month 24
Cost-Effectiveness measured using a self-report survey of Healthcare Utilization
through study completion, an average of two years
Survival
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Usual Care
1 of 2
Nurse AMIE Supportive Care Intervention
1 of 2
Active Control
Experimental Treatment
344 Total Participants · 2 Treatment Groups
Primary Treatment: Nurse AMIE · No Placebo Group · N/A
Nurse AMIE Supportive Care Intervention
Behavioral
Experimental Group · 1 Intervention: Nurse AMIE · Intervention Types: BehavioralUsual Care
Behavioral
ActiveComparator Group · 1 Intervention: Usual Care · Intervention Types: BehavioralTreatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nurse AMIE
2017
N/A
~10
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of two years
Who is running the clinical trial?
Milton S. Hershey Medical CenterLead Sponsor
461 Previous Clinical Trials
2,784,237 Total Patients Enrolled
West Virginia UniversityOTHER
161 Previous Clinical Trials
50,093 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,092 Previous Clinical Trials
41,142,416 Total Patients Enrolled
Mount Nittany Medical CenterUNKNOWN
Kathryn Schmitz, PhDPrincipal InvestigatorPenn State College of Medicine
10 Previous Clinical Trials
1,406 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You are 18 years of age or older.
You are receiving pharmacologic treatment, for the purpose of treating your cancer (i.e.
You live in a county with RUCC code 4 to 9 and/or zip code with RUCA code 4-10.
You have access to a personal device capable of receiving telephone calls for study facilitator check-ins.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments